is dbp:wikiPageUsesTemplate
of |
- dbr:Canakinumab
- dbr:Sarilumab
- dbr:Basiliximab
- dbr:Benralizumab
- dbr:Briakinumab
- dbr:Denileukin_diftitox
- dbr:Anti-IL-6
- dbr:Perakizumab
- dbr:Reslizumab
- dbr:Rilonacept
- dbr:Ustekinumab
- dbr:Interleukin
- dbr:Interleukin-10_receptor
- dbr:Interleukin-11_receptor
- dbr:Interleukin-12_receptor
- dbr:Interleukin-12_subunit_beta
- dbr:Interleukin-13_receptor
- dbr:Interleukin-15_receptor
- dbr:Interleukin-17_receptor
- dbr:Interleukin-18_receptor
- dbr:Interleukin-1_receptor
- dbr:Interleukin-1_receptor_family
- dbr:Interleukin-20_receptor
- dbr:Interleukin-21_receptor
- dbr:Interleukin-22_receptor
- dbr:Interleukin-23_receptor
- dbr:Interleukin-27_receptor
- dbr:Interleukin-28_receptor
- dbr:Interleukin-31_receptor
- dbr:Interleukin-3_receptor
- dbr:Interleukin-4_receptor
- dbr:Interleukin-5_receptor
- dbr:Interleukin-6_receptor
- dbr:Interleukin-7_receptor
- dbr:Interleukin-7_receptor-α
- dbr:Interleukin-8_receptor
- dbr:Interleukin-9_receptor
- dbr:Interleukin_1-alpha
- dbr:Interleukin_10
- dbr:Interleukin_10_receptor,_alpha_subunit
- dbr:Interleukin_10_receptor,_beta_subunit
- dbr:Interleukin_11
- dbr:Interleukin_12
- dbr:Interleukin_12_receptor,_beta_1_subunit
- dbr:Interleukin_13
- dbr:Interleukin_13_receptor,_alpha_1
- dbr:Interleukin_15
- dbr:Interleukin_16
- dbr:Interleukin_17
- dbr:Interleukin_18
- dbr:Interleukin_19
- dbr:Interleukin_1_beta
- dbr:Interleukin_1_receptor,_type_I
- dbr:Interleukin_1_receptor,_type_II
- dbr:Interleukin_1_receptor_antagonist
- dbr:Interleukin_2
- dbr:Interleukin_20
- dbr:Interleukin_20_receptor,_alpha_subunit
- dbr:Interleukin_21
- dbr:Interleukin_22
- dbr:Interleukin_23
- dbr:Interleukin_23_subunit_alpha
- dbr:Interleukin_24
- dbr:Interleukin_25
- dbr:Interleukin_26
- dbr:Interleukin_28
- dbr:Interleukin_28_receptor,_alpha_subunit
- dbr:Interleukin_29
- dbr:Interleukin_3
- dbr:Interleukin_31
- dbr:Interleukin_32
- dbr:Interleukin_33
- dbr:Interleukin_34
- dbr:Interleukin_35
- dbr:Interleukin_36
- dbr:Interleukin_36_receptor_antagonist
- dbr:Interleukin_4
- dbr:Interleukin_5
- dbr:Interleukin_5_receptor_alpha_subunit
- dbr:Interleukin_6
- dbr:Interleukin_7
- dbr:Interleukin_8
- dbr:Interleukin_8_receptor,_alpha
- dbr:Interleukin_8_receptor,_beta
- dbr:Interleukin_9
- dbr:Interleukin_receptor
- dbr:IL31RA
- dbr:Clazakizumab
- dbr:Elsilimomab
- dbr:Gevokizumab
- dbr:Interleukin_11_receptor_alpha_subunit
- dbr:Anrukinzumab
- dbr:Siltuximab
- dbr:Sirukumab
- dbr:Common_gamma_chain
- dbr:Brodalumab
- dbr:Tildrakizumab
- dbr:Tocilizumab
- dbr:Tralokinumab
- dbr:Tucotuzumab_celmoleukin
- dbr:Anakinra
- dbr:Daclizumab
- dbr:Dupilumab
- dbr:Alpha-taxilin
- dbr:Fezakinumab
- dbr:Pascolizumab
- dbr:Glycoprotein_130
- dbr:Guselkumab
- dbr:Ixekizumab
- dbr:EBI3
- dbr:Type_II_cytokine_receptor
- dbr:Lebrikizumab
- dbr:ST2_cardiac_biomarker
- dbr:CD4
- dbr:IL12A
- dbr:IL17A
- dbr:IL18BP
- dbr:IL1F10
- dbr:IL1RL1
- dbr:IL1RL2
- dbr:IL2RB
- dbr:IL36A
- dbr:IL36B
- dbr:Inolimomab
- dbr:Interleukin-1_family
- dbr:Mepolizumab
- dbr:Olokizumab
- dbr:Oprelvekin
- dbr:Secukinumab
- dbr:CSF2RB
- dbr:IL-10_family
- dbr:IL-2_receptor
- dbr:IL13RA2
- dbr:IL17RA
- dbr:IL17RB
- dbr:IL17RC
- dbr:IL17RD
- dbr:IL18R1
- dbr:IL18RAP
- dbr:IL1RAP
- dbr:IL22RA1
- dbr:IL22RA2
- dbr:IL2RA
- dbr:IL36G
- dbr:IL3RA
- dbr:Promegapoietin
- dbr:Type_I_cytokine_receptor
- dbr:Fletikumab
- dbr:Pitrakinra
- dbr:Interferon_Lambda_3
- dbr:Interleukin_12_receptor,_beta_2_subunit
- dbr:Interleukin_15_receptor,_alpha_subunit
- dbr:Interleukin_20_receptor,_beta_subunit
- dbr:Interleukin_27_receptor,_alpha_subunit
|